BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $1,326,505 (100.0% shares, 0.0% debt)

Holdings (8)

STAA STAAR SURGICAL CO 45.9%

Value ($000) $609,431 Shares 8,592,007 Est. Cost $8.21 Unrealized +684.7%

MNST MONSTER BEVERAGE CORP NEW 32.5%

Value ($000) $431,656 Shares 4,656,488 Est. Cost $22.71 Unrealized +91.5%

IWM ISHARES TR 8.8%

Value ($000) $116,858 Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 5.3%

Value ($000) $70,815 Shares 760,062 Est. Cost $27.50 Unrealized +284.5%

LCTX LINEAGE CELL THERAPEUTICS IN 4.2%

Value ($000) $55,198 Shares 34,935,485 Est. Cost $1.04 Unrealized +26.2%

— ONCOCYTE CORP 1.6%

Value ($000) $21,011 Shares 23,353,697 Est. Cost $2.75 Unrealized —

— BTRS HOLDINGS INC 1.5%

Value ($000) $19,809 Shares 3,977,701 Est. Cost $4.98 Unrealized —

— AGEX THERAPEUTICS INC 0.1%

Value ($000) $1,727 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,592,007	$609,431	45.9%	$8.21	+684.7%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$431,656	32.5%	$22.71	+91.5%	COM	61174X109
IWM	ISHARES TR	690,000	$116,858	8.8%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$70,815	5.3%	$27.50	+284.5%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$55,198	4.2%	$1.04	+26.2%	COM	53566P109
—	ONCOCYTE CORP	23,353,697	$21,011	1.6%	$2.75	—	COM	68235C107
—	BTRS HOLDINGS INC	3,977,701	$19,809	1.5%	$4.98	—	COM CL 1	11778X104
—	AGEX THERAPEUTICS INC	2,997,156	$1,727	0.1%	$2.99	—	COM	00848H108